Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Halford

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Lancet. Gastroenterology & Hepatology|December 16, 2024
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their familiesJulie Jemutai, Louise Downs, Motswedi Anderson, et al.
The Lancet Regional Health. Europe|June 10, 2026
From targets to real world impact: a review of models of care for chronic HBV and HCV in EuropeCamila A Picchio, Aina Nicolàs, Erika Duffell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2024
Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysisSeth Inzaule, Philippa Easterbrook, Ashley Latona, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
Journal of Viral Hepatitis|May 27, 2024
Peer support for people living with hepatitis B virus-A foundation for treatment expansionLouise O Downs, Kenneth Kabagambe, Sarah Williams, et al.
The Lancet. Microbe|April 12, 2025
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldSheila F Lumley, Jolynne Mokaya, Tongai G Maponga, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Lancet. Gastroenterology & Hepatology|December 16, 2024
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their familiesJulie Jemutai, Louise Downs, Motswedi Anderson, et al.
The Lancet Regional Health. Europe|June 10, 2026
From targets to real world impact: a review of models of care for chronic HBV and HCV in EuropeCamila A Picchio, Aina Nicolàs, Erika Duffell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 3, 2024
Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysisSeth Inzaule, Philippa Easterbrook, Ashley Latona, et al.
Wellcome Open Research|August 19, 2021
Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis CGraham S Cooke, Sarah Pett, Leanne McCabe, et al.
Journal of Viral Hepatitis|May 27, 2024
Peer support for people living with hepatitis B virus-A foundation for treatment expansionLouise O Downs, Kenneth Kabagambe, Sarah Williams, et al.
The Lancet. Microbe|April 12, 2025
Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the fieldSheila F Lumley, Jolynne Mokaya, Tongai G Maponga, et al.
Pageof 2